Terry-Ann Burrell
Chief Financial Officer, Beam Therapeutics.
Companies
- Recursion PharmaceuticalsBoard member Apr 15, 2021 to Jul 3, 20241
- Rapport Therapeutics, Inc.Board member Jun 6, 2024 to Jun 6, 20242
- Beam TherapeuticsChief financial officer Feb 5, 2020 to Apr 29, 20243
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Beam Therapeutics BEAM82,637 shares4$2.0M at $24.00Apr 26, 2024
Recursion Pharmaceuticals RXRX71,254 shares5$259.0K at $3.63Jul 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2024Granted 1,843 shares of Recursion Pharmaceuticals5
- Jun 3, 2024Granted 13,097 shares of Recursion Pharmaceuticals6
- Apr 26, 2024Granted 12,500 shares of Beam Therapeutics4
- Apr 1, 2024Granted 1,467 shares of Recursion Pharmaceuticals7
- Apr 1, 2024Sold 5,446 shares at $32.12 of Beam Therapeutics8
- Mar 31, 2024Granted 27,500 shares of Beam Therapeutics9
- Jul 13, 2023Sold 8,275 shares at $12.59 of Recursion Pharmaceuticals10
- Jul 12, 2023Sold 3,157 shares at $14.08 of Recursion Pharmaceuticals10
- Jul 12, 2023Sold 3,195 shares at $13.18 of Recursion Pharmaceuticals10
- Jul 12, 2023Sold 78,071 shares at $12.15 of Recursion Pharmaceuticals10
- Jul 12, 2023Sold 24,302 shares at $11.25 of Recursion Pharmaceuticals10
- Jun 16, 2023Granted 12,612 shares of Recursion Pharmaceuticals11
- Apr 4, 2023Sold 2,186 shares at $29.09 of Beam Therapeutics12
- Apr 3, 2023Sold 2,454 shares at $30.31 of Beam Therapeutics12
- Mar 31, 2023Granted 20,000 shares of Beam Therapeutics13
- Jan 27, 2023Sold 36,152 shares at $45.08 of Beam Therapeutics14
- Jan 27, 2023Exercised options 36,152 shares at $13.68 of Beam Therapeutics14
- Jan 26, 2023Sold 1,102 shares at $45.16 of Beam Therapeutics14
- Jan 26, 2023Exercised options 1,102 shares at $13.68 of Beam Therapeutics14
- Jan 24, 2023Sold 14,810 shares at $45.01 of Beam Therapeutics15
- Jan 24, 2023Exercised options 14,810 shares at $13.68 of Beam Therapeutics15
- Jan 23, 2023Sold 5,426 shares at $45.02 of Beam Therapeutics15
- Jan 23, 2023Exercised options 5,426 shares at $13.68 of Beam Therapeutics15
- Jan 18, 2023Sold 47,195 shares at $45.14 of Beam Therapeutics16
- Jan 18, 2023Exercised options 39,886 shares at $13.68 of Beam Therapeutics16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 5, 2024
- 7SEC EDGARForm 4 filed Apr 3, 2024
- 8SEC EDGARForm 4 filed Apr 3, 2024
- 9SEC EDGARForm 4 filed Apr 2, 2024
- 10SEC EDGARForm 4 filed Jul 14, 2023
- 11SEC EDGARForm 4 filed Jun 21, 2023
- 12SEC EDGARForm 4 filed Apr 5, 2023
- 13SEC EDGARForm 4 filed Mar 31, 2023
- 14SEC EDGARForm 4 filed Jan 30, 2023
- 15SEC EDGARForm 4 filed Jan 25, 2023
- 16SEC EDGARForm 4 filed Jan 20, 2023